Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ELRIG Announces Drug Discovery 2014 Programme and Pre-Conference SLAS Short Courses

Published: Monday, August 04, 2014
Last Updated: Monday, August 04, 2014
Bookmark and Share
Now in its 8th year, the conference and exhibition is the largest drug discovery meeting in the UK, and is expected to attract over 1000 delegates.

ELRIG (European Laboratory Robotics Interest Group) announced details of the programme for Drug Discovery 2014. The event provides an opportunity for scientists from all fields of early stage drug discovery to network throughout the two days, and to hear world class speakers present on the latest challenges, opportunities and advances. Registration for the event is free, and delegates can register online at www.elrig.org.

The 2014 event will feature a programme of scientific presentations, an exhibition area with around 100 vendor booths, networking opportunities, poster sessions, Dragons Den, Authors Workshop, Innovation Zone, Media Area and Careers Zone, and for the first time a series of Core Technologies Workshops, providing a more informal, interactive environment in which to discuss key issues and future directions, coordinated by leaders in their fields. There will be eight Scientific Sessions altogether, with three new sessions covering cutting-edge topics: Phenotypic Discovery & Cellular Imaging; Chemical Innovation in Lead Discovery; and Neuroscience Drug Targets.

The Scientific Sessions will feature presentations from leading scientists, including the show keynote address from Dr Susan Galbraith, Head of Oncology at AstraZeneca, on ‘Genetic drivers of cancer growth and resistance mechanisms’. Other speakers include: Lorenz Mayr, AstraZeneca; Daniela Gabriel, Novartis; Olli Kallioniemi, FIMM, Helsinki; Stefan Offermans, Max Planck; Dario Neri, ETH, Zurich; Lutz Jermuntas, MedImmune; and Eric Karran, Alzheimers Research UK.

For a full listing of speakers and sessions, visit http://elrig.org/drug-discovery-2014-overview/

In partnership with SLAS, this year’s conference will be preceded by a series of one day short courses, which will take place on Monday 1st September. For more information and to book a place, visit www.elrig.org/portfolio/slas-short-courses-drug-discovery-2014. The courses comprise:

Course 1: Introduction to Laboratory Automation
Course 2: High Content Screening: Instrumentation, Assay Development, Screening, Image and Data Analysis
Course 3: Establishing Cell-Based Assays and Implementing 3D Culture Models for Screening and drug testing


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ELRIG Announces Drug Discovery 2012 Keynotes and Workshops
European Laboratory Robotics Interest Group have announced details of the keynote speakers and workshop programme for its 6th Annual Drug Discovery Conference.
Tuesday, August 14, 2012
ELRIG Announces Speaker Programme for Drug Discovery 2012 Conference
The 6th Annual Drug Discovery Conference, in collaboration with SLAS, will be held at Manchester Central Convention Complex on 5th – 6th September 2012.
Monday, April 30, 2012
ELRIG Drug Discovery 2011
The 5th ELRIG Drug Discovery show, held in Manchester on 7 & 8th September 2011, attracted 1,125 delegates and a record number of exhibitors.
Thursday, September 22, 2011
ELRIG – Cell Based Screening
This was a meeting of records and firsts for ELRIG, being the first meeting of 2011 with record numbers of attendees at a 1 Day meeting.
Tuesday, March 22, 2011
ELRIG Drug Discovery 2011
Preparations are well underway for the 5th Annual ELRIG Drug Discovery Conference to be held at Manchester Central on 7th & 8th September 2011.
Thursday, January 27, 2011
ELRIG Drug Discovery 2010 - Free Online Registration – Book you place Now
ELRIG, the European Laboratory Robotics Interest Group, are proud to announce that FREE registration to Drug Discovery 2010 is open online. Drug Discovery 2010 will be held at the Ricoh Arena, Coventry, UK on 1st and 2nd September 2010.
Monday, August 02, 2010
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!